| Lastest Insider Transactions Of Bicara Therapeutics Inc. ( BCAX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2026-04-27 | Sell | 5,500 | 22.88 | 125,830 | 2026-04-28 19:49:27 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2026-04-27 | Option Exercise | 5,500 | 3.79 | 20,844 | 2026-04-28 19:49:27 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-04-21 | Sell | 9,200 | 23.00 | 211,614 | 2026-04-22 16:53:33 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-04-21 | Option Exercise | 9,200 | 3.79 | 34,866 | 2026-04-22 16:53:33 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-04-16 | Sell | 15,000 | 23.61 | 354,146 | 2026-04-20 19:27:09 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-04-16 | Option Exercise | 37,760 | 4.24 | 160,206 | 2026-04-20 19:27:09 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-04-15 | Sell | 12,500 | 23.01 | 287,591 | 2026-04-17 16:55:17 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-04-15 | Option Exercise | 8,000 | 3.79 | 30,318 | 2026-04-17 16:55:17 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2026-03-25 | Sell | 5,500 | 18.95 | 104,229 | 2026-03-26 19:21:14 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2026-03-25 | Option Exercise | 5,500 | 3.79 | 20,844 | 2026-03-26 19:21:14 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-03-23 | Sell | 9,200 | 18.52 | 170,348 | 2026-03-24 19:45:02 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-03-23 | Option Exercise | 9,200 | 3.79 | 34,866 | 2026-03-24 19:45:02 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-03-18 | Sell | 15,000 | 18.82 | 282,366 | 2026-03-20 17:02:58 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-03-18 | Option Exercise | 15,000 | 3.79 | 56,847 | 2026-03-20 17:02:58 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-03-16 | Sell | 12,500 | 19.66 | 245,714 | 2026-03-17 17:36:59 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-03-16 | Option Exercise | 8,000 | 3.79 | 30,318 | 2026-03-17 17:36:59 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-03-09 | Sell | 36,766 | 19.17 | 704,657 | 2026-03-11 16:47:17 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-03-09 | Option Exercise | 36,766 | 3.79 | 139,336 | 2026-03-11 16:47:17 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-03-04 | Sell | 8,234 | 18.74 | 154,325 | 2026-03-06 19:27:37 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2026-03-04 | Option Exercise | 8,234 | 3.79 | 31,205 | 2026-03-06 19:27:37 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-03-03 | Sell | 17,392 | 18.16 | 315,893 | 2026-03-05 19:10:29 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-03-03 | Option Exercise | 12,892 | 3.79 | 48,858 | 2026-03-05 19:10:29 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-03-03 | Sell | 16,518 | 18.22 | 300,971 | 2026-03-05 19:08:52 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-03-03 | Option Exercise | 16,518 | 3.79 | 62,600 | 2026-03-05 19:08:52 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2026-03-03 | Sell | 16,500 | 18.52 | 305,610 | 2026-03-05 19:06:35 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2026-03-03 | Option Exercise | 16,500 | 3.79 | 62,532 | 2026-03-05 19:06:35 |
| BCAX | Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior 10% Owner | 2026-02-26 | Buy | 300,000 | 16.00 | 4,800,000 | 2026-03-02 16:22:58 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-02-25 | Sell | 3,631 | 18.04 | 65,501 | 2026-02-27 16:13:56 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-02-25 | Option Exercise | 3,108 | 3.79 | 11,779 | 2026-02-27 16:13:56 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-01-22 | Sell | 3,828 | 18.10 | 69,296 | 2026-01-26 16:34:51 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-01-22 | Sell | 1,882 | 18.15 | 34,162 | 2026-01-26 16:33:41 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2026-01-22 | Option Exercise | 1,882 | 3.79 | 7,132 | 2026-01-26 16:33:41 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2026-01-15 | Sell | 149 | 18.02 | 2,685 | 2026-01-20 16:52:40 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-12-26 | Option Exercise | 25,000 | 4.44 | 110,923 | 2025-12-29 17:18:10 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-12-26 | Option Exercise | 25,000 | 4.44 | 110,923 | 2025-12-29 17:18:10 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2025-12-26 | Option Exercise | 19,789 | 3.79 | 74,996 | 2025-12-29 17:10:18 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-12-22 | Sell | 9,200 | 18.31 | 168,492 | 2025-12-23 16:02:23 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-12-22 | Option Exercise | 9,200 | 3.79 | 34,866 | 2025-12-23 16:02:23 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2025-12-16 | Option Exercise | 29,500 | 5.45 | 160,884 | 2025-12-18 18:02:57 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-12-15 | Sell | 12,500 | 18.68 | 233,548 | 2025-12-16 16:52:02 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-12-15 | Option Exercise | 8,000 | 3.79 | 30,318 | 2025-12-16 16:52:02 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-11-21 | Sell | 18,400 | 18.54 | 341,074 | 2025-11-25 18:42:14 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-11-21 | Option Exercise | 18,400 | 3.79 | 69,732 | 2025-11-25 18:42:14 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-11-21 | Sell | 18,400 | 18.54 | 341,074 | 2025-11-25 18:42:14 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-11-21 | Option Exercise | 18,400 | 3.79 | 69,732 | 2025-11-25 18:42:14 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-11-21 | Sell | 12,500 | 18.05 | 225,588 | 2025-11-25 18:41:34 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-11-21 | Option Exercise | 8,000 | 3.79 | 30,318 | 2025-11-25 18:41:34 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-11-21 | Sell | 12,500 | 18.05 | 225,588 | 2025-11-25 18:41:34 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-11-21 | Option Exercise | 8,000 | 3.79 | 30,318 | 2025-11-25 18:41:34 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2025-11-24 | Sell | 41,163 | 18.86 | 776,429 | 2025-11-25 18:40:40 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2025-11-24 | Option Exercise | 41,163 | 3.79 | 156,000 | 2025-11-25 18:40:40 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2025-11-24 | Sell | 11,000 | 18.65 | 205,108 | 2025-11-25 18:39:48 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2025-11-24 | Option Exercise | 11,000 | 3.79 | 41,688 | 2025-11-25 18:39:48 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-10-15 | Sell | 12,500 | 18.16 | 226,943 | 2025-10-16 16:41:41 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-10-15 | Option Exercise | 8,000 | 3.79 | 30,318 | 2025-10-16 16:41:41 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2025-10-13 | Sell | 24,734 | 18.88 | 466,936 | 2025-10-15 18:00:17 |
| BCAX | Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer | 2025-10-13 | Option Exercise | 24,734 | 3.79 | 93,737 | 2025-10-15 18:00:17 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2025-10-09 | Sell | 22,000 | 18.45 | 405,900 | 2025-10-10 17:23:20 |
| BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Officer | 2025-10-09 | Option Exercise | 22,000 | 3.79 | 83,376 | 2025-10-10 17:23:20 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-10-09 | Sell | 6,415 | 18.23 | 116,931 | 2025-10-10 17:22:56 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-10-09 | Option Exercise | 6,415 | 3.79 | 24,312 | 2025-10-10 17:22:56 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-10-06 | Sell | 30,385 | 18.21 | 553,198 | 2025-10-08 17:33:51 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-10-06 | Option Exercise | 30,385 | 3.79 | 115,153 | 2025-10-08 17:33:51 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-10-06 | Sell | 30,385 | 18.21 | 553,198 | 2025-10-08 17:33:51 |
| BCAX | Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | 2025-10-06 | Option Exercise | 30,385 | 3.79 | 115,153 | 2025-10-08 17:33:51 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-10-06 | Sell | 50,500 | 18.06 | 911,842 | 2025-10-08 17:33:28 |
| BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | President and COO | 2025-10-06 | Option Exercise | 32,000 | 3.79 | 121,274 | 2025-10-08 17:33:28 |
| BCAX | Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | 2025-09-29 | Sell | 33,807 | 14.75 | 498,653 | 2025-10-01 16:57:33 |
| BCAX | Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | 2025-09-29 | Option Exercise | 33,807 | 9.24 | 312,495 | 2025-10-01 16:57:33 |
| BCAX | Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | 2025-06-16 | Sell | 15,829 | 10.43 | 165,096 | 2025-06-18 17:12:19 |
| BCAX | Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | 2025-06-16 | Option Exercise | 15,829 | 5.45 | 86,268 | 2025-06-18 17:12:19 |
| BCAX | Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | 2025-03-14 | Sell | 79,146 | 12.90 | 1,021,211 | 2025-03-18 18:35:25 |
| BCAX | Bicara Therapeutics Inc. | Meisner Lara | Chief Legal Officer | 2025-03-14 | Option Exercise | 79,146 | 5.45 | 431,346 | 2025-03-18 18:35:25 |
| BCAX | Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior 10% Owner | 2024-09-16 | Buy | 1,833,000 | 18.00 | 32,994,000 | 2024-09-18 18:02:36 |
| BCAX | Bicara Therapeutics Inc. | Flynn James E | 10% Owner | 2024-09-17 | Buy | 70,000 | 18.00 | 1,260,000 | 2024-09-17 18:16:55 |
